| abstract |
(1) a therapeutically effective amount of a 9-hydroxy-risperidone fatty acid ester or a salt thereof, or a stereoisomer or mixture of stereoisomers as an active ingredient; And (2) a pharmaceutically acceptable carrier; A pharmaceutical composition suitable as a depot formulation for administration by intramuscular or subcutaneous injection characterized in that the pharmaceutically acceptable carrier is water and the active ingredient is suspended therein; And to a process for preparing such compositions. The present invention also relates to a method of treating behavioral disorders associated with schizophrenia, non-schizophrenic psychoses, neurodegenerative diseases (e.g., dementia), behavioral disorders in mental retardation and autism, bipolar mania, depression, anxiety To a pharmaceutical composition for use as a medicament. |